|
1
|
Efferth T, Xu AL and Lee DYW: Combining
the wisdoms of traditional medicine with cutting-edge science and
technology at the forefront of medical sciences. Phytomedicine.
64:1530782019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wang Y, Yi X, Ghanam K, Zhang S, Zhao T
and Zhu X: Berberine decreases cholesterol levels in rats through
multiple mechanisms, including inhibition of cholesterol
absorption. Metabolism. 63:1167–1177. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kong W, Wei J, Abidi P, Lin M, Inaba S, Li
C, Wang Y, Wang Z, Si S, Pan H, et al: Berberine is a novel
cholesterol-lowering drug working through a unique mechanism
distinct from statins. Nat Med. 10:1344–1351. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hou Q, He WJ, Wu YS, Hao HJ, Xie XY and Fu
XB: Berberine: A Traditional Natural Product With Novel Biological
Activities. Altern Ther Health Med. 26S:20–27. 2020.PubMed/NCBI
|
|
5
|
Chen QQ, Shi JM, Ding Z, Xia Q, Zheng TS,
Ren YB, Li M and Fan LH: Berberine induces apoptosis in
non-small-cell lung cancer cells by upregulating miR-19a targeting
tissue factor. Cancer Manag Res. 11:9005–9015. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sun Y, Wang W and Tong Y: Berberine
Inhibits Proliferative Ability of Breast Cancer Cells by Reducing
Metadherin. Med Sci Monit. 25:9058–9066. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Refaat A, Abdelhamed S, Yagita H, Inoue H,
Yokoyama S, Hayakawa Y and Saiki I: Berberine enhances tumor
necrosis factor-related apoptosis-inducing ligand-mediated
apoptosis in breast cancer. Oncol Lett. 6:840–844. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kim JS, Oh D, Yim MJ, Park JJ, Kang KR,
Cho IA, Moon SM, Oh JS, You JS, Kim CS, et al: Berberine induces
FasL-related apoptosis through p38 activation in KB human oral
cancer cells. Oncol Rep. 33:1775–1782. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jiang SX, Qi B, Yao WJ, Gu CW, Wei XF,
Zhao Y, Liu YZ and Zhao BS: Berberine displays antitumor activity
in esophageal cancer cells in vitro. World J Gastroenterol.
23:2511–2518. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Luo Y, Tian G, Zhuang Z, Chen J, You N,
Zhuo L, Liang B, Song Y, Zang S, Liu J, et al: Berberine prevents
non-alcoholic steatohepatitis-derived hepatocellular carcinoma by
inhibiting inflammation and angiogenesis in mice. Am J Transl Res.
11:2668–2682. 2019.PubMed/NCBI
|
|
11
|
Kou Y, Li L, Li H, Tan Y, Li B, Wang K and
Du B: Berberine suppressed epithelial mesenchymal transition
through cross-talk regulation of PI3K/AKT and RARα/RARβ in melanoma
cells. Biochem Biophys Res Commun. 479:290–296. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Maiti P, Plemmons A and Dunbar GL:
Combination treatment of berberine and solid lipid curcumin
particles increased cell death and inhibited PI3K/Akt/mTOR pathway
of human cultured glioblastoma cells more effectively than did
individual treatments. PLoS One. 14:e02256602019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Abrams SL, Follo MY, Steelman LS,
Lertpiriyapong K, Cocco L, Ratti S, Martelli AM, Candido S, Libra
M, Murata RM, et al: Abilities of berberine and chemically modified
berberines to inhibit proliferation of pancreatic cancer cells. Adv
Biol Regul. 71:172–182. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Warburg O: On the origin of cancer cells.
Science. 123:309–314. 1956. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Massari F, Ciccarese C, Santoni M,
Iacovelli R, Mazzucchelli R, Piva F, Scarpelli M, Berardi R,
Tortora G, Lopez-Beltran A, et al: Metabolic phenotype of bladder
cancer. Cancer Treat Rev. 45:46–57. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xiao H, Wang J, Yan W, Cui Y, Chen Z, Gao
X, Wen X and Chen J: GLUT1 regulates cell glycolysis and
proliferation in prostate cancer. Prostate. 78:86–94. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Powles T, Murray I, Brock C, Oliver T and
Avril N: Molecular positron emission tomography and PET/CT imaging
in urological malignancies. Eur Urol. 51:1511–1520; discussion
1520–1521. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Deng D, Xu C, Sun P, Wu J, Yan C, Hu M and
Yan N: Crystal structure of the human glucose transporter GLUT1.
Nature. 510:121–125. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Reinicke K, Sotomayor P, Cisterna P,
Delgado C, Nualart F and Godoy A: Cellular distribution of Glut-1
and Glut-5 in benign and malignant human prostate tissue. J Cell
Biochem. 113:553–562. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yu M, Yongzhi H, Chen S, Luo X, Lin Y,
Zhou Y, Jin H, Hou B, Deng Y, Tu L, et al: The prognostic value of
GLUT1 in cancers: A systematic review and meta-analysis.
Oncotarget. 8:43356–43367. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Amann T, Maegdefrau U, Hartmann A, Agaimy
A, Marienhagen J, Weiss TS, Stoeltzing O, Warnecke C, Schölmerich
J, Oefner PJ, et al: GLUT1 expression is increased in
hepatocellular carcinoma and promotes tumorigenesis. Am J Pathol.
174:1544–1552. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Oh S, Kim H, Nam K and Shin I: Glut1
promotes cell proliferation, migration and invasion by regulating
epidermal growth factor receptor and integrin signaling in
triple-negative breast cancer cells. BMB Rep. 50:132–137. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chan DA, Sutphin PD, Nguyen P, Turcotte S,
Lai EW, Banh A, Reynolds GE, Chi JT, Wu J, Solow-Cordero DE, et al:
Targeting GLUT1 and the Warburg effect in renal cell carcinoma by
chemical synthetic lethality. Sci Transl Med. 3:94ra702011.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Δ Δ C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Fearnhead HO, Vandenabeele P and Vanden
Berghe T: How do we fit ferroptosis in the family of regulated cell
death? Cell Death Differ. 24:1991–1998. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Boado RJ: Post-transcription modulation of
the blood-brain barrier GLUT1 glucose transporter by brain-derived
factors. J Neural Transm Suppl. 59:255–261. 2000.PubMed/NCBI
|
|
28
|
Giorgino F, de Robertis O, Laviola L,
Montrone C, Perrini S, McCowen KC and Smith RJ: The
sentrin-conjugating enzyme mUbc9 interacts with GLUT4 and GLUT1
glucose transporters and regulates transporter levels in skeletal
muscle cells. Proc Natl Acad Sci USA. 97:1125–1130. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wieman HL, Horn SR, Jacobs SR, Altman BJ,
Kornbluth S and Rathmell JC: An essential role for the Glut1
PDZ-binding motif in growth factor regulation of Glut1 degradation
and trafficking. Biochem J. 418:345–367. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Balakrishna A and Kumar MH: Evaluation of
Synergetic Anticancer Activity of Berberine and Curcumin on
Different Models of A549, Hep-G2, MCF-7, Jurkat, and K562 Cell
Lines. BioMed Res Int. 2015:3546142015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yu R, Zhang ZQ, Wang B, Jiang HX, Cheng L
and Shen LM: Berberine-induced apoptotic and autophagic death of
HepG2 cells requires AMPK activation. Cancer Cell Int. 14:492014.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lebelo MT, Joubert AM and Visagie MH:
Warburg effect and its role in tumourigenesis. Arch Pharm Res.
42:833–847. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kennedy KM and Dewhirst MW: Tumor
metabolism of lactate: The influence and therapeutic potential for
MCT and CD147 regulation. Future Oncol. 6:127–148. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Semenza GL: Tumor metabolism: Cancer cells
give and take lactate. J Clin Invest. 118:3835–3837.
2008.PubMed/NCBI
|
|
35
|
Mao L, Chen Q, Gong K, Xu X, Xie Y, Zhang
W, Cao H, Hu T, Hong X and Zhan YY: Berberine decelerates glucose
metabolism via suppression of mTOR dependent HIF 1α protein
synthesis in colon cancer cells. Oncol Rep. 39:2436–2442.
2018.PubMed/NCBI
|
|
36
|
Ruan H, Zhan YY, Hou J, Xu B, Chen B, Tian
Y, Wu D, Zhao Y, Zhang Y, Chen X, et al: Berberine binds RXRα to
suppress β-catenin signaling in colon cancer cells. Oncogene.
36:6906–6918. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wang Y and Zhang S: Berberine suppresses
growth and metastasis of endometrial cancer cells via
miR-101/COX-2. Biomed Pharmacother. 103:1287–1293. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Pan Y, Shao D, Zhao Y, Zhang F, Zheng X,
Tan Y, He K, Li J and Chen L: Berberine Reverses Hypoxia-induced
Chemoresistance in Breast Cancer through the Inhibition of AMPK-
HIF-1α. Int J Biol Sci. 13:794–803. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Liu L, Fan J, Ai G, Liu J, Luo N, Li C and
Cheng Z: Berberine in combination with cisplatin induces
necroptosis and apoptosis in ovarian cancer cells. Biol Res.
52:372019. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Tong X and Pelling JC: Targeting the
PI3K/Akt/mTOR axis by apigenin for cancer prevention. Anticancer
Agents Med Chem. 13:971–978. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Gismondi A, Nanni V, Monteleone V, Colao
C, Di Marco G and Canini A: Plant miR171 modulates mTOR pathway in
HEK293 cells by targeting GNA12. Mol Biol Rep. 48:435–449. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Alolga RN, Fan Y, Chen Z, Liu LW, Zhao YJ,
Li J, Chen Y, Lai MD, Li P and Qi LW: Significant pharmacokinetic
differences of berberine are attributable to variations in gut
microbiota between Africans and Chinese. Sci Rep. 6:276712016.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Farooqi AA, Qureshi MZ, Khalid S, Attar R,
Martinelli C, Sabitaliyevich UY, Nurmurzayevich SB, Taverna S,
Poltronieri P and Xu B: Regulation of cell signaling pathways by
berberine in different cancers: Searching for missing pieces of an
incomplete jig-saw puzzle for an effective cancer therapy. Cancers
(Basel). 11:4782019. View Article : Google Scholar : PubMed/NCBI
|
